tiprankstipranks
Abattis Bioceuticals Corp (ATTBF)
OTHER OTC:ATTBF
US Market

Abattis Bioceuticals (ATTBF) Financial Statements

172 Followers

Abattis Bioceuticals Financial Overview

Abattis Bioceuticals's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Abattis Bioceuticals is scheduled to report earnings on October 14, 2020, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 19Jun 19Mar 19Dec 18Sep 18
Income Statement-
Total RevenueC$ 723.18KC$ 127.79KC$ 2.17KC$ 643.00C$ 2.47K
Gross ProfitC$ 659.05KC$ 76.39KC$ 2.17K-C$ 2.47K
EBITC$ -1.57MC$ -730.37KC$ -142.54KC$ -1.25MC$ -49.50M
EBITDAC$ -1.52MC$ -709.12KC$ -121.45KC$ -1.23MC$ -51.40M
Net Income Common StockholdersC$ -907.06KC$ -735.66KC$ -142.54KC$ -1.26MC$ -54.20M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 2.40MC$ 3.39MC$ 4.68MC$ 5.76MC$ 9.10M
Total AssetsC$ 19.26MC$ 20.41MC$ 13.13MC$ 13.15MC$ 11.40M
Total DebtC$ 150.86KC$ 1.49MC$ 0.00C$ 0.00C$ 0.00
Net DebtC$ -2.25MC$ -1.91MC$ -4.68MC$ -5.76MC$ -9.10M
Total LiabilitiesC$ 8.59MC$ 8.80MC$ 325.60KC$ 381.73KC$ 303.16K
Stockholders EquityC$ 10.67MC$ 12.00MC$ 13.20MC$ 13.16MC$ 11.49M
Cash Flow-
Free Cash FlowC$ 3.93MC$ 7.50MC$ -607.48KC$ -1.44MC$ -1.50M
Operating Cash FlowC$ 3.93MC$ 5.48MC$ -590.04KC$ -1.43MC$ -1.47M
Investing Cash FlowC$ -4.61MC$ -6.91MC$ 1.62MC$ -55.23KC$ -528.35K
Financing Cash Flow-C$ 60.00KC$ 0.00C$ 60.00KC$ 482.28K
Currency in CAD

Abattis Bioceuticals Earnings and Revenue History

Abattis Bioceuticals Debt to Assets

Abattis Bioceuticals Cash Flow

Abattis Bioceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis